Glaxo Pays $41 Million to Settle U.S. Drug-Quality Issue

June 24, 2011
At issue was the poor quality of a plant in Puerto Rico that is now closed.

To settle allegations of poor drug quality at a manufacturing plant in Puerto Rico, British pharmaceutical giant GlaxoSmithKline said on June 24 that it is paying $41 million.

The company did not admit to any wrongdoing at the now shuttered factory, but said it agreed to the settlement "to avoid the expense and uncertainty of protracted litigation and trial."

The payment will be distributed across 37 states and the District of Columbia.

"The company did not admit to any wrongdoing or liability of any kind under these states' consumer protection laws in this settlement," the statement said. At the center of the dispute is a plant in Cidra. A company insider told the US news show 60 Minutes in January that contaminated and poorly dosed medications were being produced there. A federal investigation ensued.

GlaxoSmithKline rejected the accusations and said there was no evidence that patients had been harmed.

Federal regulators, the U.S. Department of Justice and the whistelblower Cheryl Eckard's attorney, "all stated there was no indication that patients were harmed as a result of the production issues at Cidra," the company said in response to the CBS report.

GlaxoSmithKline said it closed the plant in 2009 because of "declining demand for the medicines made there."

Before selling the factory in 2010, the drugmaker insisted it "brought it into compliance and to a high level of performance that satisfied both GSK and the FDA."

Copyright Agence France-Presse, 2011

Popular Sponsored Recommendations

Digitally Transforming Data and Processes With Product Lifecycle Management

Oct. 29, 2023
Manufacturers face increasing challenges in product development as they strive to consistently deliver improved results. Discover how industry leaders are improving time-to-market...

Why DataOps may be the key to unlocking the full potential of digital transformation

Nov. 3, 2023
Read the 2023 market survey conducted by IndustryWeek

Modern Edge Computing Accelerates Smart Manufacturing Initiatives for Discrete Manufacturers

Oct. 22, 2023
Discover how Edge Computing platforms are a requisite for discrete manufacturers to solve production challenges, accelerate digitalization, and establish a reliable infrastructure...

The Manufacturer's Guide to Modernizing Commercial Operations

Sept. 12, 2023
In this guide, learn how a modern approach to commercial operations can help your manufacturing business integrate sales and revenue management to elevate seller productivity ...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!